Annexon Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting classical complement-mediated disorders affecting the body, brain, and eye. The company leverages its proprietary platform technology to address autoimmune and neurodegenerative diseases triggered by the aberrant activation of C1q, a key molecule in the classical complement pathway. Its lead product candidate, ANX005, is a monoclonal antibody designed for intravenous use in treating autoimmune and neurodegenerative conditions, while ANX007 is formulated for intravitreal administration to address neurodegenerative ophthalmic disorders. Annexon is committed to advancing its pipeline through a disciplined, biomarker-driven development strategy, aiming to demonstrate the efficacy and safety of its therapies in various patient populations.

Administration

South San Francisco, CA, USA

Annexon Biosciences

Healthcare

Correlation Ventures

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Correlation Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Correlation Ventures network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Correlation Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Companies you’ll love to work for